Johns Hopkins University Press
Abstract

People experiencing homelessness (PEH) have a high prevalence of mental illness and substance use disorder (SUD) and substantial acute and chronic disease burden. Transitional care and medical respite programs facilitate a safe transfer for PEH from the acute care to community setting. Many medical respite programs practice harm reduction strategies that can increase the opportunity for positive program outcomes for PEH with SUD. This transitional care and medical respite program evaluation explored program outcomes, health care utilization patterns, and comorbid conditions of persons with and without SUD. People experiencing homelessness with SUD had similar program outcomes and both groups had decreased acute care utilization after program engagement. A high prevalence of trimorbidity, which is associated with early mortality, was noted. Opportunities for harm reduction strategies to promote both social and clinical outcomes are offered.

Key words

Homelessness, substance use disorders, health care utilization, medical respite, program evaluation, program outcomes, Elixhauser, trimorbidity, comorbidity

People experiencing homelessness (PEH) have a high rate of premature death; a high prevalence of serious mental illness, acute and chronic diseases, and substance use disorders (SUD);1 and a standardized mortality ratio two to five times higher than that of the general population.1 Comorbid conditions are common in the population and the incidence of trimorbidity (i.e., the combination of mental illness, SUD, and chronic medical illnesses), which is associated with premature mortality, is increasing.2 These poor health outcomes are hampered by multiple barriers to accessing health care3 and are reflected in high-cost health service utilization rates.1 Compared with [End Page 1337] those who do not experience homelessness, PEH have 30-day emergency department (ED) revisit rates that are 5.7 times higher, and 30-day hospital readmission rates that are 1.9 times higher.4

There is a strong association between homelessness and SUD,5,6 and a significant number of PEH who are patients in the ED setting report alcohol and substance use.7 Despite this linkage, there is limited evidence regarding interventions and programs that address problematic substance use for PEH.5,7 PEH report that their needs are not well met when accessing health or SUD treatment services.5,7 Because PEH frequently require health care services as well as SUD treatment, there is an impetus for the development and assessment of innovative care models to meet these needs.5,7

Medical respite is a promising model to address the health care and social needs of PEH with SUD.8 Medical respite programs offer short-term residential stays for PEH who are too ill to recover safely from illness or injury while unhoused.9 Medical respite programs vary in organizational models, services provided, and patient populations served.9 The variety of services provided include case management, clinical care, aftercare planning, referrals, transportation to medical services, facilitating meals, and more.9 Patient-centered care is a cornerstone of medical respite programs.10 A medical respite stay that meets basic needs (e.g., shelter, food, clothing, access to care) allows PEH to arrange plans for the future,11 including SUD treatment. Because SUD may be a barrier to engagement in medical respite programs for PEH12 and is associated with premature program exit,13 programs operate with harm reduction strategies not requiring abstinence from substances.14,15

In response to the rising number of PEH being discharged from area hospitals with ongoing medical needs, members of our team developed and implemented a two-year medical respite pilot program. Program participants demonstrated several positive outcomes including connection to primary care, mental health care, SUD treatment, and improved housing. A pre-post comparison of health service outcomes demonstrated decreased hospital admissions and inpatient days and increased outpatient visits.16 These data supported funding for an expansion of the pilot program, which is now known as Durham Homeless Care Transitions (DHCT).

Durham Homeless Care Transitions was begun five years ago, and a robust program evaluation is underway. The present study compares the comorbidity profile of a patient cohort who participated in DHCT with those who did not, evaluates DHCT program outcomes for PEH with and without SUD, and reports health care utilization patterns for DHCT program enrollees with and without SUD before program enrollment and after program discharge.

Methods

Study design

This program evaluation used (a) retrospective chart review data to explore patient comorbid conditions and determine health care utilization patterns of people with and without SUD before, during, and after DHCT program engagement and (b) DHCT program data to assess program outcomes. Our primary goals were (1) to describe patients referred to and enrolled in DHCT; (2) to report program outcomes of DHCT participants including health care utilization before program enrollment [End Page 1338] and after program discharge; and (3) to report the differential effect of the program for patients with diagnosed SUD. The research questions that guided this study were:

  1. 1. What is the prevalence of SUD in patients referred to and enrolled in DHCT?

  2. 2. What is the chronic illness, mental health, and SUD burden of patients referred to and enrolled into DHCT including co-occurring disorders and trimorbidity?

  3. 3. Do patients with SUD have program outcomes the same or similar to those of patients without SUD?

  4. 4. What are the health care utilization patterns of DHCT patients pre-, during-, and post-program and how do they vary for patients with SUD?

  5. 5. Does a SUD diagnosis predict enrollment in the DHCT program?

This project was reviewed and approved by the Duke Health Institutional Review Board.

Setting and participants

All patients who were referred to DHCT from July 1, 2016 through June 30, 2020 (n = 497) were included in the study. Health care utilization patterns and program outcomes are presented for all people who were admitted to the program and discharged on or before January 1, 2020 (n = 125) to allow for six months of post-program health care service utilization data.

The Durham Homeless Care Transitions (DHCT) Program

The Durham Homeless Care Transition Program provides case consultation, medical respite services (a safe place to rest and recover upon hospital or medical discharge), and care management to PEH with acute or chronic medical issues. It began in 2016 as a nine-month intensive case management program with the goal of connecting PEH with ongoing medical needs to existing services (e.g., primary care, SUD services, mental health care) and supports (e.g., housing, income, family or friends, community groups). In time, we realized that not all patients required, or desired, this level of case management; therefore, we developed and piloted a novel triage system to determine patient medical vulnerability and anticipated program case management needs. The Durham Homeless Care Transition Program does not provide direct medical care but connects clients to existing community and health care services. The Durham Homeless Care Transition Program uses a scattered-sites model for patients, providing housing in either double- or single-room occupancy sober houses or hotel rooms.

The Durham Homeless Care Transition Program is administered by Project Access of Durham County (PADC) and was primarily funded during the study period through programmatic grants, along with lesser amounts of funding from Durham County, Duke University Health System (DUHS), and the Duke Outpatient Clinic. All DHCT referrals and enrollees were on the SUD spectrum (i.e., at risk for SUD to active addiction) and may have had mental illness. The Durham Homeless Care Transition Program is grounded in a harm reduction approach that facilitates helping individuals connect to resources tailored to their needs such as strict sobriety or reduced intake, or medication-assisted therapy (e.g., for alcohol use disorder or opiate use disorder). The team maintains connections with local mental health and substance use systems in our community and we make referrals as individuals become ready. We provide clients with Narcan kits and can connect individuals to needle exchange opportunities.

In line with our harm reduction philosophy, we do not require sobriety for medical respite placement or housing placement. The majority of our medical respite placements [End Page 1339]

. DHCT PROGRAM ELIGIBILITY CRITERIA

No description available
Click for larger view
View full resolution

are in scattered site sober housing settings where we can provide room and board for individuals who were recently discharged from the hospital. For individuals who are unable to or uninterested in maintaining sobriety, we have provided higher-cost hotelbased respite. As we work towards housing plans for our homeless clients, we do not require sobriety from individuals who may have SUD in addition to primary medical issues; rather, our philosophy mirrors the Housing First approach with a goal of stabilizing individuals' housing as a first step towards stabilizing their broader health.17

At the time of this evaluation, program staff included an operations director (10% effort), a nurse practitioner clinical director (25% effort), a program evaluator (5% effort), a program or case manager (1.0 FTE), and a housing specialist (1.0 FTE). The majority of DHCT clients were referred by complex care coordinators within the local academic health system through an electronic portal. The clinical director, who works within the health system, reviewed the referral information and clinical information housed in the electronic health record (EHR) and determined whether the client met DHCT program admission criteria (Box 1). If the patient met DHCT program criteria, the patient was eligible for the program with care management planning for a safe discharge back into a community setting. If the patient was experiencing homelessness and did not have a safe place to recover from their illness or injury, DHCT provided medical respite housing. If the patient chose not to engage with or was ineligible for DHCT, the clinical director served as an expert consultant to the referring agency to facilitate a safe discharge plan for the patient, which included skilled nursing or assisted living facilities.

Once enrolled into the program, the DHCT case manager or clinical director met with the patient to complete intake information and added them to the DHCT program electronic informatics platform. Intake information included:

  1. 1. a Has/Needs form to document items and services that the client already had as well as those for which they might qualify, [End Page 1340]

  2. 2. a health survey,

  3. 3. a self-efficacy tool,

  4. 4. the Vulnerability Index Service Prioritization Decision Assistance Tool (VI-SPDAT, Version 1)18 which was included in housing prioritization metrics in Durham, NC, and

  5. 5. the Montreal Cognitive Assessment (MoCA)19 to assess cognitive function.

The team resurveyed items 1–3 at three-month intervals during program engagement.

Service frequency and intensity were tailored to individual patient situations and the complexity of medical conditions. Services included referrals to medical and social service agencies, appointment and transportation arrangements, and accompaniment to appointments. Housing needs were assessed upon enrollment and, if needed, a housing specialist was engaged to submit housing applications based on patient qualifications and preferences. The Durham Homeless Care Transition Program was designed to help patients make the transition from the hospital setting back into community care. Once clients were medically stable and reliably established with community care providers and social service agencies as determined by the clinical director, they were discharged from the program.

Data collection

The Durham Homeless Care Transition Program programmatic data are housed within two Research Electronic Data Capture (REDCap)20 databases: one for referrals and one for participant tracking. Everyone has a medical record number from the local academic health system that allows linkage of data between the databases. To access EHR data, identifiers for all referrals, including full name, date of birth, and health system medical record number were downloaded into an Excel spreadsheet and shared with the Duke Health Technology Solutions Analytics Center of Excellence (DHTS ACE) for matching within the DUHS EHR, which includes outpatient information from Lincoln Community Health Center (the local federally qualified health center). Data were abstracted for all matched referrals from the EHR go live date of January 1, 2014 through June 30, 2020. Multiple variables at both the patient and encounter level as well as diagnoses and financial data were included. The cleaned dataset was delivered into a protected computing environment for storage and analysis. The Durham Homeless Care Transition Program programmatic data were downloaded into an Excel spreadsheet from their individual REDCap databases.

Measures

Elixhauser comorbidity index

The Elixhauser comorbidity index was developed to define clinical comorbidities associated with hospital length of stay, hospital charges, and in-hospital death.21 The final algorithm included 30 distinct comorbidities classified by International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes. In 2005, the algorithm was updated to reflect changes brought about by implementation of ICD, Tenth Revision (ICD-10).22 The Elixhauser Comorbidity Index is widely used in health services research.23

Defining SUD and chronic conditions

Chronic illness status was assessed by using the Elixhauser comorbidity index to determine medical conditions documented in the EHR data that preceded the DHCT referral date. Among the Elixhauser comorbidity items are Drug Abuse and Alcohol Abuse; participants whose EHR reflected the ICD-10 codes for either of those conditions were categorized as Yes for SUD. In a similar manner, [End Page 1341] each of the 30 Elixhauser items were also categorized as Yes or No based on whether their ICD-10 code was documented in the EHR prior to the referral date. The following additional six umbrella categories of chronic conditions were constructed if the subject had a Yes to any of the individual Elixhauser items: (1) Heart Disease included congestive heart failure, valvular disease, and cardiac arrhythmia; (2) Hypertension included both complicated and uncomplicated hypertension; (3) Diabetes included both complicated and uncomplicated diabetes; (4) Cancer included lymphoma, metastatic cancer, and solid tumor without metastasis; (5) Mental Illness included psychoses and depression (i.e., the Elixhauser descriptive terms) (6) Trimorbidity was defined as Yes if the subject was Yes to mental illness, SUD, and one or more Elixhauser-efined chronic conditions. (More information on the Elixhauser Comorditiy Index, including the ICD-10 codes specific to each diagnoses category, is available at: https://www.hcup-us.ahrq.gov/toolssoftware/comorbidity/comorbidity.jsp.)

Statistical analyses

We used descriptive statistics to categorize the health care utilization and demographic variables. Substance use disorder group (Yes and No) characteristics were compared using t-tests for continuous variables and chi-square tests for categorical variables. Normality of continuous variables was assessed to satisfy parametric analytic assumptions. With the binary outcome variable of acceptance into the DHCT program (Yes or No), logistic regression was used to evaluate a set of candidate predictors. For DHCT participants, analysis of utilization of hospital resources (ED visits, inpatient admissions, total bed days, and observation encounters) pre-DHCT enrollment compared with post-DHCT discharge were conducted as change scores. For variables such as number of admissions that were counts in nature, Poisson regression was used to compare the SUD groups. All analyses were conducted using SAS 9.4 (SAS Inc., Cary, NC). Significance was assessed at p = .05.

Results

In the four-year period beginning July 1, 2016 through June 30, 2020, the DHCT program had 576 referrals of 497 unique individuals. Table 1 presents participant characteristics of (a) all referrals, (b) participants with and without diagnosed SUD, and (c) DHCT program participants. The mean age of people referred to the program was 50.5 ± 11. The majority were men (68.6%), non-Hispanic Black (61.2%), had diagnosed SUD (66.3%), had public insurance (42.4%), and were referred from the academic health system (61%) (Table 1). Of referrals who were not accepted into the program, 290 had documentation regarding the reason. The top five reasons for program exclusion included: 1) unable to contact (22%), 2) the person refused (17%), 3) no medical need (12%), 4) higher level of care required (11%), and 5) not experiencing homelessness.

On average, PEH referred to DHCT had high comorbid chronic illness, particularly heart disease, hypertension, chronic pulmonary disease, and diabetes. The Durham Homeless Care Transitions program participants had greater prevalence of these and other chronic illnesses compared with the cohort not enrolled in the program. Additionally, almost three quarters of DHCT program participants had SUD, 73% had SUD co-occurring with at least one chronic illness, and more than half had trimorbidity (Table 2). [End Page 1342]

Table 1. PARTICIPANT CHARACTERISTICS
Click for larger view
View full resolution
Table 1.

PARTICIPANT CHARACTERISTICS

Greater than 90% of DHCT program participants obtained or maintained a primary care medical home, obtained or maintained connection with a medical specialty care provider, and received medication assistance (Table 3). More than 75% had facilitated access to transportation, improved their housing arrangement, and reconnected with family or friends. Program participants with SUD were more likely than those without SUD to obtain or maintain SUD treatment (61.1% vs 36.7%; p = .019) and obtain or maintain mental health care (66.3% vs 46.7%; p = .054). There were no other statistically significant differences in program outcomes between groups. Patients who were uninsured were less likely than those with public insurance to be enrolled into the DHCT program (OR = .466; .276 to .787), and those with SUD were more likely to be enrolled (OR = 1.662; 1.021 to 2.704).

A comparison of health care utilization in the six months before program enrollment and six months after program exit demonstrated that DHCT participants had lower average counts of hospital admissions (1.63 vs .62; p < .0001), bed days (16.37 vs 5.41; p < .0001), and ED visits (3.25 vs 1.71; p < .0001) (Table 4). Comparing health [End Page 1343]

Table 2. ELIXHAUSER SCALE DIAGNOSES OF PARTICIPANTS, % WITH CONDITION*
Click for larger view
View full resolution
Table 2.

ELIXHAUSER SCALE DIAGNOSES OF PARTICIPANTS, % WITH CONDITION*

care utilization six months prior to enrollment with utilization during the program revealed a decrease in mean admissions (1.63 vs 1.00; p = .0002), bed days (16.37 vs 8.87; p = .004) and an increase in outpatient visits (6.78 vs 17.63; p < .0001). Patients without SUD had higher mean observation encounters than patients with SUD (.47 vs 1.27; p = .007). [End Page 1344]

Table 3. DHCT PROGRAM SERVICES RECEIVED FOR PATIENTS WITH AND WITHOUT SUD
Click for larger view
View full resolution
Table 3.

DHCT PROGRAM SERVICES RECEIVED FOR PATIENTS WITH AND WITHOUT SUD

[End Page 1345]

Table 4. DHCT PROGRAM PARTICIPANT HEALTH CARE UTILIZATION PRE, DURING, AND POST PROGRAM AT +/- 6 MONTHS
Click for larger view
View full resolution
Table 4.

DHCT PROGRAM PARTICIPANT HEALTH CARE UTILIZATION PRE, DURING, AND POST PROGRAM AT +/- 6 MONTHS

[End Page 1346]

Discussion

This study explored health conditions at referral and programmatic outcomes and health care utilization patterns of PEH before and after engagement with a homeless medical respite and transitional care program. Considering the program's use of harm reduction strategies, we found it notable that there was a lack of difference in outcome for participants with and without SUD. All DHCT program participants, both with and without SUD, demonstrated increased access to social services including exiting the program with an improved housing arrangement, income source, health care insurance, and established support system including reconnection with family and friends. These findings are like those in the few studies that report social outcomes of medical respite.16,2426

Although we cannot directly attribute these outcomes to harm reduction strategies, prior research has demonstrated that PEH with SUD have had positive clinical outcomes in harm reduction environments. For example, Beieler et al.14 demonstrated successful outpatient parenteral antimicrobial therapy for 64% of patients with a history of injection drug use treated in a medical respite program. Harm reduction strategies in their program included information on needle exchange, Narcan kits, safer injection practices, and opiate replacement therapy for patients who were interested.14 More recently, Beieler at al.27 demonstrated that patients who had a bundle of interventions that included medications for opioid use disorder begun in the inpatient setting had increased odds for clinical cure of serious infections during their medical respite stay. Risteau and colleagues15 implemented a managed alcohol program to decrease the potential for alcohol withdrawal and increase compliance with COVID-19-related isolation and quarantine orders for PEH and those who could not shelter in place. Early program outcomes showed that patients were able to adhere to isolation and quarantine orders and noted no serious adverse events or deaths during the two-month program implementation phase.15

The National Health Care for the Homeless Council (NHCHC), the preeminent authority on homeless medical respite, has published medical respite standards.28 Outcomes associated with Standard 5 (Medical Respite Program Assists in Health Care Coordination and Provides Wrap-Around Support Services) include facilitating connection to primary, mental health, SUD care, transportation, housing, and benefit programs, as well as access to social support groups including family and caregivers. Future medical respite research and program evaluation should highlight these important outcomes as well as the more frequently reported findings of changes in health care utilization and associated cost savings. An important contribution of the current study is that both PEH with and without SUD attained these outcomes. Although not designed as SUD treatment, medical respite serves as an important connection to medical and mental health care as well as SUD treatment for PEH.

Health care utilization is a metric frequently used to demonstrate medical respite program value. Consistent with prior studies, following a transitional care or medical respite program, patients had decreased hospital admissions,16,28,29 fewer bed days,16,29 and less ED utilization. 29 The current study demonstrates these decreases in PEH with and without diagnosed SUD. Our study did not evaluate hospital readmission rates, [End Page 1347] however others that did showed promising results.4,30,31 Future medical respite program research and evaluations can work to replicate these findings, which may help with medical respite program initiation in new areas and sustainability for existing programs as well as attract the attention of funders and insurers.

Expanding Medicaid in the remaining 12 states that have yet to extend single adult coverage and including medical respite as a Medicaid-reimbursable service may assist with establishing and maintaining medical respite programs as well as achieving more positive outcomes for PEH (a highly marginalized group). It is important to note that PEH, especially those who had little to no contact with the health care system prior to an injury or illness, may not achieve decreased utilization. Exploring other metrics is warranted, such as hospital risk mitigation for safely discharging PEH, increased provider and discharge planner satisfaction, increased patient satisfaction, improved health system public image, and alignment of health system priorities and values with the larger community.

Like previous studies, PEH in our study exhibited a high prevalence of chronic illness, SUD, and mental illness; co-occurring disorders (i.e., mental illness or SUD with one or more chronic conditions) and trimorbidity were also particularly high. While not a new classification, reports of trimorbidity among PEH are increasing in the literature. Trimorbidity is a complex multimorbid condition as the associated illnesses often potentiate one another32 and, for PEH, are associated with risk for unplanned hospital admissions33 and death.34 Vickery and colleagues2 demonstrated a substantial increase in trimorbidity of PEH in Minnesota with rates increasing from 7.9% in 2000 to 16.3% in 2018.2 In a study by Stringfellow et al.35 39% of current or formerly PEH who were engaged in primary care met trimorbidity criteria. In the current study, almost half of PEH referred and not accepted into DHCT and more than half of DHCT program participants had trimorbidity as evidenced by EHR documentation. People experiencing homelessness with trimorbidity have different needs and care considerations from PEH without trimorbidity.35,36 Further research to determine the prevalence of trimorbidity in larger cohorts of PEH, including initial EHR review or validating self-reports of trimorbidity in the EHR, is warranted.

To our knowledge, this is the first study to explore medical respite program outcomes and health service utilization before and after medical respite engagement by PEH with and without SUD. The study has several limitations. First, the small sample size, particularly for program participants, limits statistical analyses and generalizability. Second, participants had varying lengths of time and levels of engagement with the program, and it is unclear if there is a dose response relative to medical respite care. Third, the study used a pre / post design rather than a comparison or control group, which limits the strength of the associations and outcomes reported. Fourth, the indicator of SUD comes from codes assigned to participants by practitioners in the medical setting, not a formal SUD evaluation. Because of this, participants may be mislabeled as having SUD without undergoing proper evaluation that would indicate SUD. Alternatively, other participants who actually have SUD may be underrepresented because they were not coded as having SUD in the clinical setting. This could explain why the evaluation shows that participants who were not categorized as having SUD still utilized SUD services. These limitations notwithstanding, the study contributes to [End Page 1348] the existing knowledge base on medical respite outcomes and demonstrates how these outcomes are attainable by PEH with and without SUD.

Donna J. Biederman, Richard Sloane, Julia Gamble, Christine Sverchek, and Timothy P. Daaleman

DONNA J. BIEDERMAN and CHRISTINE SVERCHEK are affiliated with the Duke University School of Nursing. RICHARD SLOANE is affiliated with the Center on Aging at the Duke University School of Medicine. JULIA GAMBLE is affiliated with the Duke Outpatient Clinic. TIMOTHY P. DAALEMAN is affiliated with the University of North Carolina Chapel Hill.

Please address all correspondence to Donna J. Biederman, Duke University School of Nursing, DUMC 3322, Durham, NC 27710; phone: (919)-684-8849; email: donna.biederman@duke.edu.

Acknowledgments

We would like to thank Sally Wilson of Project Access of Durham County for her work in helping to initiate and sustain the DHCT program. This project is included as part of the Duke School of Medicine Opioid Collaboratory portfolio, grant-funded by the Duke Endowment and administered through the Duke Department of Population Health Sciences. The Collaboratory's mission is to save lives and reduce the harmful impact of opioids in North Carolina through the development, implementation, and evaluation of system-level interventions.

References

1. Fazel S, Geddes JR, Kushel M. The health of homeless people in high-income countries: descriptive epidemiology, health consequences, and clinical and policy recommendations. Lancet. 2014;384(9953):1529–40. https://doi.org/10.1016/S0140-6736(14)61132-6
2. Vickery KD, Winkelman TNA, Ford BR, et al. Trends in trimorbidity among adults experiencing homelessness in Minnesota, 2000–2018. Med Care. 2021 Apr 1;59(Suppl 2):S220–7. https://doi.org/10.1097/MLR.0000000000001435 PMid:33710099
3. Zur J, Linton S, Mead H. Medical respite and linkages to outpatient health care providers among individuals experiencing homelessness. J Community Health Nurs. 2016;33(2):81–9. https://doi.org/10.1080/07370016.2016.1159439 PMid:27074404
4. Shetler D, Shepard DS. Medical respite for people experiencing homelessness: financial impacts with alternative levels of Medicaid coverage. J Health Care Poor Underserved. 2018 May;29(2):801–13. https://doi.org/10.1353/hpu.2018.0059 PMid:29805141
5. Carver H, Ring N, Miler J, et al. What constitutes effective problematic substance use treatment from the perspective of people who are homeless? A systematic review and meta-ethnography. Harm Reduct J. 2020 Jan 31;17(1):10. https://doi.org/10.1186/s12954-020-0356-9 PMid:32005119
6. McVicar D, Moschion J, Van Ours JC. From substance use to homelessness or vice versa? Soc Sci Med. 2015 Jul;136–137:89–98. Epub 2015 May 2. https://doi.org/10.1016/j.socscimed.2015.05.005 PMid:25989002
7. Doran KM, Rahai N, McCormack RP, et al. Substance use and homelessness among emergency department patients. Drug Alcohol Depend. 2018 Jul 1;188:328–33. Epub 2018 May 22. https://doi.org/10.1016/j.drugalcdep.2018.04.021 PMid:29852450
8. United States Interagency Council on Homelessness. Opening Doors: federal strategic plan to prevent and end homelessness. Washington, DC: United States Interagency Council on Homelessness, 2015. Available at https://www.usich.gov/resources/uploads/asset_library/USICH_OpeningDoors_Amendment2015_FINAL.pdf.
9. National Health Care for the Homeless Council. Medical respite directory. Nashville, TN: National Health Care for the Homeless Council, 2021. Available at https://nhchc.org/clinical-practice/medical-respite-care/medical-respite-directory/.
10. National Institute for Medical Respite Care. Medical respite literature review: an update on the evidence for medical respite care. Nashville, TN: National Institute for Medical Respite Care, 2021. Available at https://nimrc.org/wp-content/uploads/2021/03/NIMRC_Medical-Respite-Literature-Review.pdf.
11. Pedersen M, Bring C, Brünés N, et al. Homeless people's experiences of medical respite care following acute hospitalisation in Denmark. Health Soc Care Community. 2018 Jul;26(4):538–46. Epub 2018 Feb 28. https://doi.org/10.1111/hsc.12550 PMid:29488273
12. Kimmel SD, Bazzi AR, Barocas JA. Integrating harm reduction and clinical care: lessons from COVID-19 respite and recuperation facilities. J Subst Abuse Treat. 2020 Nov;118:108103. Epub 2020 Aug 12. https://doi.org/10.1016/j.jsat.2020.108103 PMid:32972644
13. Bauer J, Moughamian A, Viloria J, et al. Leaving before discharge from a homeless medical respite program: predisposing factors and impact on selected outcomes. J Health Care Poor Underserved. 2012 Aug;23(3):1092–105. https://doi.org/10.1353/hpu.2012.0118 PMid:24212162
14. Beieler AM, Dellit TH, Chan JD, et al. Successful implementation of outpatient parenteral antimicrobial therapy at a medical respite facility for homeless patients. J Hosp Med. 2016 Aug;11(8):531–5. Epub 2016 Apr 27. https://doi.org/10.1002/jhm.2597 PMid:27120700
15. Ristau J, Mehtani N, Gomez S, et al. Successful implementation of managed alcohol programs in the San Francisco Bay Area during the COVID-19 crisis. Subst Abus. 2021;42(2):140–7. Epub 2021 Apr 13. https://doi.org/10.1080/08897077.2021.1892012 PMid:33848451
16. Biederman DJ, Gamble J, Wilson S, et al. Health care utilization following a homeless medical respite pilot program. Public Health Nurs. 2019 May;36(3):296–302. Epub 2019 Feb 11. https://doi.org/10.1111/phn.12589 PMid:30746762
17. Baxter AJ, Tweed EJ, Katikireddi SV, et al. Effects of Housing First approaches on health and well-being of adults who are homeless or at risk for homelessness: a systematic review and meta-analysis of randomised controlled trials. J Epidemiol Community Health. 2019 May;73(5):379–87. Epub 2019 Feb 18. https://doi.org/10.1136/jech-2018-210981 PMid:30777888
18. Community Solutions, OrgCode Consulting, Inc. Vulnerability index (VI) & service prioritization decision assistance tool (SPDAT): Prescreen assessment for single adults. Martinez, CA: Community Solutions, 2013. Available at https://myccclink.cchealth.org/h3/coc/pdf/2014-0521-packet-2.pdf.
19. Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005 Apr;53(4):695–9. https://doi.org/10.1111/j.1532-5415.2005.53221.x PMid:15817019
20. Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap). A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009 Apr;42(2):377–81. Epub 2008 Sep 30. https://doi.org/10.1016/j.jbi.2008.08.010 PMid:18929686
21. Elixhauser A, Steiner C, Harris DR, et al. Comorbidity measures for use with administrative data. Med Care. 1998 Jan;36(1):8–27. https://doi.org/10.1097/00005650-199801000-00004 PMid:9431328
22. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005 Nov;43(11):1130–9. https://doi.org/10.1097/01.mlr.0000182534.19832.83 PMid:16224307
23. Austin SR, Wong Y-N, Uzzo RG, et al. Why summary comorbidity measures such as the Charlson Comorbidity Index and Elixhauser score work. Med Care. 2015 Sep;53(9):e65–72. https://doi.org/10.1097/MLR.0b013e318297429c PMid:23703645
24. Meschede T. Accessing housing: exploring the impact of medical and substance abuse services on housing attainment for chronically homeless street dwellers. J Hum Behav Soc Environ. 2010;20(2):153–69. https://doi.org/10.1080/10911350903269880
25. Zerger S. An evaluation of the respite pilot initiative. Nashville, TN: National Health Care for the Homeless Council, 2006. Available at https://nhchc.org/wp-content/uploads/2019/08/RespiteRpt0306.pdf.
26. Beieler AM, Klein JW, Bhatraju E, et al. Evaluation of bundled interventions for patients with opioid use disorder experiencing homelessness receiving extended antibiotics for severe infection. Open Forum Infect Dis. 2021 May 29;8(6):ofab285. https://doi.org/10.1093/ofid/ofab285 PMid:34189180
27. National Health Care for the Homeless Council. Standards for medical respite/recuperative care programs. Nashville, TN: National Institute for Medical Respite Care, 2016. Available at http://nimrc.org/standards-for-medical-respite-programs/.
28. Buchanan D, Doblin B, Sai T, et al. The effects of respite care for homeless patients: a cohort study. Am J Public Health. 2006 Jul;96(7):1278–81. Epub 2006 May 30. https://doi.org/10.2105/AJPH.2005.067850 PMid:16735635
29. Sadowski LS, Kee RA, VanderWeele TJ, et al. Effect of a housing and case management program on emergency department visits and hospitalizations among chronically ill homeless adults: a randomized trial. JAMA. 2009 May 6;301(17):1771–8. https://doi.org/10.1001/jama.2009.561 PMid:19417194
30. Racine MW, Munson D, Gaeta JM, et al. Thirty-day hospital readmission among homeless individuals with Medicaid in Massachusetts. Med Care. 2020 Jan;58(1):27–32. https://doi.org/10.1097/MLR.0000000000001234 PMid:31651744
31. Doran KM, Greysen SR, Cunningham A, et al. Improving post-hospital care for people who are homeless: community-based participatory research to communitybased action. Healthc (Amst). 2015 Dec;3(4):238–44. Epub 2015 Aug 25. https://doi.org/10.1016/j.hjdsi.2015.07.006 PMid:26699351
32. Jones AA, Gicas KM, Seyedin S, et al. Associations of substance use, psychosis, and mortality among people living in precarious housing or homelessness: a longitudinal, community-based study in Vancouver, Canada. PLOS Med. 2020 Jul 6;17(7):e1003172. https://doi.org/10.1371/journal.pmed.1003172 PMid:32628679
33. Himsworth C, Paudyal P, Sargeant C. Risk factors for unplanned hospital admission in a specialist homeless general practice population: case–control study to investigate the relationship with tri-morbidity. Br J Gen Pract. 2020 May 28;70(695):e406–11. https://doi.org/10.3399/bjgp20X710141 PMid:32424048
34. Roncarati JS, O'Connell JJ, Hwang SW, et al. The use of high-risk criteria to assess mortality risk among unsheltered homeless people. J Health Care Poor Underserved. 2020 Feb;31(1):441–54. https://doi.org/10.1353/hpu.2020.0032 PMid:32037341
35. Stringfellow EJ, Kim TW, Pollio DE, et al. Primary care provider experience and social support among homeless-experienced people with tri-morbidity. Addict Sci Clin Pract. 2015;10(Suppl 1):A64. https://doi.org/10.1186/1940-0640-10-S1-A64 PMCid:PMC4347584
36. Fleury M-J, Grenier G, Sabetti J, et al. Met and unmet needs of homeless individuals at different stages of housing reintegration: a mixed-method investigation. PLOS ONE. 2021 Jan 14;16(1):e0245088. https://doi.org/10.1371/journal.pone.0245088 PMid:33444366

Share